| Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
| ttctcat |
| ttcGcat |
| -20 % |
![]() |
Data for this mutation
| Sample ID | MSH2 | MLH1 | MSH6 | MUTYH | APC |
|---|---|---|---|---|---|
| 2_02-DDM4321_1968_19684412 | - | - | - | - | - |
| Analysis | Result | Date | Origin | PMID/dbSNP |
|---|---|---|---|---|
| Co-occurrence | MLH1:c.2038T>C, p.Cys680Arg (1968-4412) | 7/07/14 | 2 (Villejuif) | |
| Clinical phenotype | Sporadic rectal cancer < 50 years old (1968-4412) | 7/07/14 | 2 (Villejuif) | |
| MMR function in tumor cells | MSI-H (BRAF p.Gln609X) / MLH1+MSH2+MSH6+PMS2+ (1968-4412) | 7/07/14 | 2 (Villejuif) |
| Biological significance | Date | Comment |
|---|---|---|
| Likely Neutral | 9/07/15 | --- |